Skip to main content
. 2020 Jul 27;20:694. doi: 10.1186/s12885-020-07161-0

Table 3.

Patient characteristics

Entire cohort 24
Histology
 Squamous cell carcinoma 19 (79%)
 Endocervical adenocarcinoma 2 (8%)
 Small cell neuroendocrine carcinoma 1 (4%)
 Low-grade squamous intraepithelial neoplasia 1 (4%)
 Invasive cervical cancer 1 (4%)
Pathogenic stage
 Stage I 6 (25%)
 Stage II 11 (46%)
 Stage III 3 (13%)
 Stage IV 4 (17%)